undamentalytics Newsletter
Sign in

Funds (13F)

Finepoint Capital LP

Backtest from 20 Feb 2015 to 2 Nov 2026 · weekly · hypothetical

Watch this strategy
Return a year
+0.5%
S&P 500 +13.4%
Last 12 months
+5.2%
S&P 500 +12.1%
Sharpe ratio
0.08
S&P 500 0.71
Biggest drop
−47.9%
S&P 500 −31.8%
$10.0k$20.0k$40.0k 201520172019202120232025 $43.5k$10.6k
Finepoint Capital LPS&P 500 $10,000 in Finepoint Capital LP from 20 Feb 2015 against the S&P 500 (total return) over the same dates, marked weekly, log scale. Hypothetical: before taxes and trading costs.

About

Copies Finepoint Capital LP's quarterly 13F holdings in the companies we cover, weighted by reported value: it buys on the first trading day after each 13F is filed (up to 45 days after the quarter) and holds until the next filing. A 13F shows long US-listed positions only, at the quarter's end, so this misses shorts, cash, bonds, non-US holdings and trading within the quarter.

Finepoint Capital LP's 13F holdings →

Key statistics

MeasureStrategyS&P 500
Return a year (compound)+0.5%+13.4%
Total return+6%+335%
Last 12 months+5.2%+12.1%
Last 3 months+4.8%—
Last month+5.8%—
This year so far−11.8%—
Volatility a year28.9%16.5%
Sharpe ratio0.080.71
Biggest drop−47.9%−31.8%
Beta to the S&P 5000.571.00
Alpha a year (t-statistic)−4.3% (−0.53)—
Share of weeks up36%—

Sharpe ratio uses returns above the 3-month Treasury bill rate. Alpha is the yearly return left after allowing for the strategy's exposure to the S&P 500 (CAPM); a t-statistic below about 2 means it cannot be told apart from luck.

Insights

CompanyWeightHeld sinceReturn since
QXO67.9%——
RXO32.1%——
ANNA0.0%——

Weighted by reported value in the latest 13F, held until the next filing.

PeriodReturn a yearS&P 500SharpeS&P 500Biggest dropBetaAlpha (t)
Whole backtest20 Feb 2015 to 2 Nov 2026+0.5%+13.4%0.080.71−47.9%0.57−4.3% (−0.53)
2018 onwards5 Jan 2018 to 2 Nov 2026−1.4%+13.9%0.020.66−47.9%0.49−5.3% (−0.53)
Last three years3 Nov 2023 to 2 Nov 2026+10.8%+21.8%0.341.16−38.6%1.09−2.5% (−0.10)
Last year7 Nov 2025 to 2 Nov 2026+8.5%+14.2%0.330.84−38.6%1.93−1.3% (−0.03)
DateCompanyAction
14 Nov 2025RXOBought
14 Feb 2025XNCRBought
14 Feb 2025ANNABought
15 Nov 2024TVTXBought
15 Nov 2024SRPTBought
15 Nov 2024SLDBBought
15 Nov 2024RVMDBought
15 Nov 2024RLAYBought
15 Nov 2024QXOBought
15 Nov 2024PRTABought
15 Nov 2024MLTXBought
15 Nov 2024LKFTBought
15 Nov 2024EYPTBought
15 Nov 2024CYTKBought
15 Nov 2024ARVNBought
15 Nov 2024ARGXBought
15 Nov 2024ACADBought

Dated at the rebalance that made the change.

DateCompanyAction
15 May 2026SLDBSold
15 Aug 2025XNCRSold
15 Aug 2025SRPTSold
15 Aug 2025RVMDSold
15 Aug 2025RLAYSold
15 Aug 2025PRTASold
15 Aug 2025MLTXSold
15 Aug 2025LKFTSold
15 Aug 2025EYPTSold
15 Aug 2025CYTKSold
15 Aug 2025ARVNSold
16 May 2025ARGXSold
14 Feb 2025TVTXSold
14 Feb 2025ACADSold

Dated at the rebalance that made the change.

Backtests are hypothetical and use today's listed companies only, which flatters results. Past performance does not predict future returns. This is research, not investment advice. How we backtest